Milestone Pharmaceuticals Inc. - Common Shares (MIST)
CUSIP: 59935V107
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Shares
- Shares outstanding
- 124,031,000
- Total 13F shares
- 20,148,798
- Share change
- -136,076
- Total reported value
- $110,818,750
- Put/Call ratio
- 15%
- Price per share
- $5.50
- Number of holders
- 26
- Value change
- -$885,245
- Number of buys
- 10
- Number of sells
- 15
Quarterly Holders Quick Answers
What is CUSIP 59935V107?
CUSIP 59935V107 identifies MIST - Milestone Pharmaceuticals Inc. - Common Shares in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 59935V107:
Top shareholders of MIST - Milestone Pharmaceuticals Inc. - Common Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
|
Company |
3.5%
|
4,315,102
|
$24,984,000 | — | 31 Mar 2021 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
2.1%
|
2,583,821
|
$14,960,000 | — | 31 Mar 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
2.1%
|
2,572,194
|
$14,893,000 | — | 31 Mar 2021 | |
| Novo Holdings A/S |
13F
|
Company |
2%
|
2,530,585
|
$14,652,000 | — | 31 Mar 2021 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
1.8%
|
2,246,503
|
$13,007,000 | — | 31 Mar 2021 | |
| Ikarian Capital, LLC |
13F
|
Company |
1.5%
|
1,836,545
|
$10,633,000 | — | 31 Mar 2021 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.69%
|
851,291
|
$4,929,000 | — | 31 Mar 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.69%
|
850,998
|
$4,927,000 | — | 31 Mar 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.58%
|
717,797
|
$4,156,000 | — | 31 Mar 2021 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.38%
|
467,640
|
$2,708,000 | — | 31 Mar 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.22%
|
267,997
|
$1,552,000 | — | 31 Mar 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.17%
|
216,400
|
$1,253,000 | — | 31 Mar 2021 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.17%
|
208,332
|
$1,206,000 | — | 31 Mar 2021 | |
| BARCLAYS PLC |
13F
|
Company |
0.13%
|
156,876
|
$909,000 | — | 31 Mar 2021 | |
| J. Goldman & Co LP |
13F
|
Company |
0.08%
|
100,283
|
$581,000 | — | 31 Mar 2021 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.05%
|
60,637
|
$351,000 | — | 31 Mar 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.05%
|
58,100
|
$336,000 | — | 31 Mar 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.04%
|
54,813
|
$317,000 | — | 31 Mar 2021 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.04%
|
50,100
|
$290,000 | — | 31 Mar 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.03%
|
38,316
|
$222,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
20,859
|
$120,000 | — | 31 Mar 2021 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.02%
|
18,704
|
$108,000 | — | 31 Mar 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.01%
|
17,016
|
$99,000 | — | 31 Mar 2021 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
13,499
|
$78,000 | — | 31 Mar 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.01%
|
12,004
|
$70,000 | — | 31 Mar 2021 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0.01%
|
10,600
|
$61,374 | — | 31 Mar 2021 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
0%
|
5,166
|
$30,000 | — | 31 Mar 2021 | |
| Sowell Financial Services LLC |
13F
|
Company |
0%
|
1,440
|
$8,000 | — | 31 Mar 2021 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
601
|
$3,000 | — | 31 Mar 2021 | |
| Wealthcare Advisory Partners LLC |
13F
|
Company |
0%
|
352
|
$2,000 | — | 31 Mar 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
303
|
$2,000 | — | 31 Mar 2021 | |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. |
13F
|
Company |
0%
|
245
|
$1,000 | — | 31 Mar 2021 |
Institutional Holders of Milestone Pharmaceuticals Inc. - Common Shares (MIST) as of Q2 2021
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.